Variation in CAPN10 in relation to type 2 diabetes, obesity and quantitative metabolic traits: Studies in 6018 whites

Molecular Genetics and Metabolism

Volumn 89, Issue 4, 2006, Pages 360-367

  Jensen, Dorit P ^a   Urhammer, Søren A ^a,b   Eiberg, Hans ^c   Borch Johnsen, Knut ^a,d,e   Jørgensen, Torben ^d   Hansen, Torben ^a   Pedersen, Oluf ^a,e  

^a STENO DIABETES CENTER   (Denmark)

^b FREDERIKSBERG HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

Author keywords

Association study; CAPN10; Genetics; Obesity; Single nucleotide polymorphism; Type 2 diabetes

Indexed keywords

CALPAIN 10; CYSTEINE PROTEASE CALPAIN 10; CYSTEINE PROTEINASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION GENETICS; PRIORITY JOURNAL; QUANTITATIVE TRAIT; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM 43; SINGLE NUCLEOTIDE POLYMORPHISM 44;

BLOOD GLUCOSE; BODY MASS INDEX; CALPAIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33750622017     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2006.06.003     Document Type: Article

References (40)

1. Hanis C.L., Boerwinkle E., Chakraborty R., Ellsworth D.L., Concannon P., Stirling B., Morrison V.A., Wapelhorst B., Spielman R.S., Gogolin-Ewens K.J., Shepard J.M., Williams S.R., Risch N., Hinds D., Iwasaki N., Ogata M., Omori Y., Petzold C., Rietzch H., Schroder H.E., Schulze J., Cox N.J., Menzel S., Boriraj V.V., Chen X., Lim L.R., Lindner T., Mereu L.E., Wang Y.Q., Xiang K., Yamagata K., Yang Y., and Bell G.I. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat. Genet. 13 (1996) 161-166
2. Horikawa Y., Oda N., Cox N.J., Li X., Orho-Melander M., Hara M., Hinokio Y., Lindner T.H., Mashima H., Schwarz P.E., Bosque-Plata L., Horikawa Y., Oda Y., Yoshiuchi I., Colilla S., Polonsky K.S., Wei S., Concannon P., Iwasaki N., Schulze J., Baier L.J., Bogardus C., Groop L., Boerwinkle E., Hanis C.L., and Bell G.I. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 26 (2000) 163-175
3. Carafoli E., and Molinari M. Calpain: a protease in search of a function?. Biochem. Biophys. Res. Commun. 247 (1998) 193-203
4. Sorimachi H., Ishiura S., and Suzuki K. Structure and physiological function of calpains. Biochem. J. 328 Pt 3 (1997) 721-732
5. Sreenan S.K., Zhou Y.P., Otani K., Hansen P.A., Currie K.P., Pan C.Y., Lee J.P., Ostrega D.M., Pugh W., Horikawa Y., Cox N.J., Hanis C.L., Burant C.F., Fox A.P., Bell G.I., and Polonsky K.S. Calpains play a role in insulin secretion and action. Diabetes 50 (2001) 2013-2020
6. Logie L.J., Brown A.E., Yeaman S.J., and Walker M. Calpain inhibition and insulin action in cultured human muscle cells. Mol. Genet. Metab. 85 (2005) 54-60
7. Garant M.J., Kao W.H., Brancati F., Coresh J., Rami T.M., Hanis C.L., Boerwinkle E., and Shuldiner A.R. Atherosclerosis Risk in Communities Study, SNP43 of CAPN10 and the risk of type 2 Diabetes in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes 51 (2002) 231-237
8. Orho-Melander M., Klannemark M., Svensson M.K., Ridderstråle M., Lindgren C.M., and Groop L. Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels. Diabetes 51 (2002) 2658-2664
9. Tsai H.J., Sun G., Weeks D.E., Kaushal R., Wolujewicz M., McGarvey S.T., Tufa J., Viali S., and Deka R. Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: no evidence of association. Am. J. Hum. Genet. 69 (2001) 1236-1244
10. Evans J.C., Frayling T.M., Cassell P.G., Saker P.J., Hitman G.A., Walker M., Levy J.C., O'Rahilly S., Rao P.V., Bennett A.J., Jones E.C., Menzel S., Prestwich P., Simecek N., Wishart M., Dhillon R., Fletcher C., Millward A., Demaine A., Wilkin T., Horikawa Y., Cox N.J., Bell G.I., Ellard S., McCarthy M.I., and Hattersley A.T. Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am. J. Hum. Genet. 69 (2001) 544-552
11. Fingerlin T.E., Erdos M.R., Watanabe R.M., Wiles K.R., Stringham H.M., Mohlke K.L., Silander K., Valle T.T., Buchanan T.A., Tuomilehto J., Bergman R.N., Boehnke M., and Collins F.S. Variation in three single nucleotide polymorphisms in the calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort. Diabetes 51 (2002) 1644-1648
12. Rasmussen S.K., Urhammer S.A., Berglund L., Jensen J.N., Hansen L., Echwald S.M., Borch-Johnsen K., Horikawa Y., Mashima H., Lithell H., Cox N.J., Hansen T., Bell G.I., and Pedersen O. Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians. Diabetes 51 (2002) 3561-3567
13. Ridderstråle M., Parikh H., and Groop L. Calpain 10 and type 2 diabetes: are we getting closer to an explanation?. Curr. Opin. Clin. Nutr. Metab. Care 8 (2005) 361-366
14. del Bosque-Plata L., Aguilar-Salinas C.A., Tusie-Luna M.T., Ramirez-Jimenez S., Rodriguez-Torres M., Auron-Gomez M., Ramirez E., Velasco-Perez M.L., Ramirez-Silva A., Gomez-Perez F., Hanis C.L., Tsuchiya T., Yoshiuchi I., Cox N.J., and Bell G.I. Association of the calpain-10 gene with type 2 diabetes mellitus in a Mexican population. Mol. Genet. Metab. 81 (2004) 122-126
15. Daimon M., Oizumi T., Saitoh T., Kameda W., Yamaguchi H., Ohnuma H., Igarashi M., Manaka H., and Kato T. Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese. Diabetes Res. Clin. Pract. 56 (2002) 147-152
16. Song Y., Niu T., Manson J.E., Kwiatkowski D.J., and Liu S. Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies. Am. J. Hum. Genet. 74 (2004) 208-222
17. Weedon M.N., Schwarz P.E., Horikawa Y., Iwasaki N., Illig T., Holle R., Rathmann W., Selisko T., Schulze J., Owen K.R., Evans J., Bosque-Plata L., Hitman G., Walker M., Levy J.C., Sampson M., Bell G.I., McCarthy M.I., Hattersley A.T., and Frayling T.M. Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. Am. J. Hum. Genet. 73 (2003) 1208-1212
18. Lyssenko V., Almgren P., Anevski D., Orho-Melander M., Sjögren M., Saloranta C., Tuomi T., and Groop L. The Botnia Study Group, Genetic prediction of future type 2 diabetes. PLoS Med. 2 (2005) 1299-1308
19. Baier L.J., Permana P.A., Yang X., Pratley R.E., Hanson R.L., Shen G.Q., Mott D., Knowler W.C., Cox N.J., Horikawa Y., Oda N., Bell G.I., and Bogardus C. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J. Clin. Invest. 106 (2000) R69-R73
20. Elbein S.C., Chu W., Ren Q., Hemphill C., Schay J., Cox N.J., Hanis C.L., and Hasstedt S.J. Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians. J. Clin. Endocrinol. Metab. 87 (2002) 650-654
21. Lynn S., Evans J.C., White C., Frayling T.M., Hattersley A.T., Turnbull D.M., Horikawa Y., Cox N.J., Bell G.I., and Walker M. Variation in the calpain-10 gene affects blood glucose levels in the British population. Diabetes 51 (2002) 247-250
22. Stumvoll M., Fritsche A., Madaus A., Stefan N., Weisser M., Machicao F., and Haring H. Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans. Diabetes 50 (2001) 2161-2163
23. Carlsson E., Fredriksson J., Groop L., and Ridderstrale M. Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese Swedish subjects. J. Clin. Endocrinol. Metab. 89 (2004) 3601-3605
24. Pihlajamäki J., Salmenniemi U., Vänttinen M., Ruotsalainen E., Kuusisto J., Vauhkonen I., Kainulainen S., Ng M.C.Y., Cox N.J., Bell G.I., and Laakso M. Common polymorphisms of calpain-10 are associated with abdominal obesity in subjects at high risk of type 2 diabetes. Diabetologia 49 (2006) 1560-1566
25. Hinney A., Antwerpen B., Geller F., Schafer H., Siegfried W., Goldschmidt H., Remschmidt H., Ziegler A., and Hebebrand J. No evidence for involvement of the calpain-10 gene 'high-risk' haplotype combination for non-insulin-dependent diabetes mellitus in early onset obesity. Mol. Genet. Metab. 76 (2002) 152-156
26. Jørgensen T., Borch-Johnsen K., Thomsen T.F., Ibsen H., Glümer C., and Pisinger C. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur. J. Cardiovasc. Prev. Rehabil. 10 (2003) 377-386
27. World Health Organization, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, Geneva, 1999.
28. Ek J., Rose C.S., Jensen D.P., Glümer C., Borch-Johnsen K., Jørgensen T., Pedersen O., and Hansen T. The functional Thr130Ile and Val255Met polymorphisms of the hepatocyte nuclear factor-4α (HNF4A): gene associations with type 2 diabetes or altered β-cell function among Danes. J. Clin. Endocrinol. Metab. 90 (2005) 3054-3059
29. Buetow K.H., Edmonson M., MacDonald R., Clifford R., Yip P., Kelley J., Little D.P., Strausberg R., Koester H., Cantor C.R., and Braun A. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc. Natl. Acad. Sci. USA 98 (2001) 581-584
30. Egger M., Davey-Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
31. Andersen G., Hansen T., and Pedersen O. Genetics of common forms of glycaemia with pathological impact on vascular biology: are we on the right track?. Curr. Mol. Med. 5 (2005) 261-274
32. Hansen L., and Pedersen O. Genetics of type 2 diabetes mellitus: status and perspectives. Diabetes Obes. Metab. 7 (2005) 122-135
33. Chen Y., Kittles R., Zhou J., Chen G., Adeyemo A., Panguluri R.K., Chen W., Amoah A., Opoku V., Acheampong J., Agyenim-Boateng K., Eghan B.A., Nyantaki A., Oli J., Okafor G., Ofoegbu E., Osotimehin B., Abbiyesuku F., Johnson T., Fasanmade O., Rufus T., Furbert-Harris P., Daniel H.I., Berg K.A., Collins F.S., Dunston G.M., and Rotimi C.N. Calpain-10 gene polymorphisms and type 2 diabetes in West Africans: the Africa America Diabetes Mellitus (AADM) Study. Ann. Epidemiol. 15 (2005) 153-159
34. Wu B., Takahashi J., Fu M., Cheng H., Matsumura S., and Taniguchi H. Variants of calpain-10 gene and its association with type 2 diabetes mellitus in a Chinese population. Diabetes Res. Clin. Pract. 68 (2005) 155-161
35. Shima Y., Nakanishi K., Odawara M., Kobayashi T., and Ohta H. Association of the SNP-19 genotype 22 in the calpain-10 gene with elevated body mass index and hemoglobin A1c levels in Japanese. Clin. Chim. Acta. 336 (2003) 89-96
36. Horikawa Y., Oda N., Yu L., Imamura S., Fujiwara K., Makino M., Seino Y., Itoh M., and Takeda J. Genetic variations in calpain-10 gene are not a major factor in the occurrence of type 2 diabetes in Japanese. J. Clin. Endocrinol. Metab. 88 (2003) 244-247
37. Malecki M.T., Moczulski D.K., Klupa T., Wanic K., Cyganek K., Frey J., and Sieradzki J. Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population. Eur. J. Endocrinol. 146 (2002) 695-699
38. Iwasaki N., Horikawa Y., Tsuchiya T., Kitamura Y., Nakamura T., Tanizawa Y., Oka Y., Hara K., Kadowaki T., Awata T., Honda M., Yamashita K., Oda N., Yu L., Yamada N., Ogata M., Kamatani N., Iwamoto Y., Bosque-Plata L., Hayes M.G., Cox N.J., and Bell G.I. Genetic variants in the calpain-10 gene and the development of type 2 diabetes in the Japanese population. J. Hum. Genet. 50 (2005) 92-98
39. Wang Y., Xiang K., Zheng T., Jia W., Shen K., and Li J. The UCSNP44 variation of calpain 10 gene on NIDDM1 locus and its impact on plasma glucose levels in type 2 diabetic patients. Zhonghua yi xue za zhi 82 (2002) 613-616
40. Cassell P.G., Jackson A.E., North B.V., Evans J.C., Syndercombe-Court D., Phillips C., Ramachandran A., Snehalatha C., Gelding S.V., Vijayaravaghan S., Curtis D., and Hitman G.A. Haplotype combinations of calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in South Indians. Diabetes 51 (2002) 1622-1628